March 2014 Clinical Laboratory News: Volume 40, Number 3

CLN Banner Logo

COVER STORIES

The Challenge of Diagnosing Encephalitis
Can Labs, Aided by New Guidelines, Help Clinicians Choose Tests More Wisely?
By Deborah Levenson

Encephalitis presents major challenges for clinicians struggling to take care of sometimes critically ill patients, and for laboratorians advising them on testing options. A new international guideline aims to streamline and improve the diagnostic process for this exceptionally serious condition.

The Rise of Big Data
Trends and Opportunities for the Lab
By Nancy B. Williams

Blending biostatistics, bioinformatics, and computer programming, big data is expected to transform the process of clinical decision-making. According to experts, labs should get ready to work with big data specialists so that they can maximize the role of the laboratorian in making sense of vast amounts of lab data.

SERIES ARTICLE

Bath Salts
Understanding a Pervasive Designer Drug
By Jeffery Moran, PhD, and Kathryn Seely, PhD

Most routine clinical toxicology tests cannot detect bath salts, nor are screening methods for them widely available. With abuse of these designer drugs rising, though, it is important for clinical laboratories to stay updated on bath salts pharmacology and testing information, and to work to develop robust detection methods that keep pace with emerging designer drugs.  

NEWS BRIEF

Public Still Wary of Genetic Cancer Testing

INSIDE

FDA to Address Concerns About New Glucose Meter Regulations
AACC Webinar March 19

In the live AACC webinar, "New Blood Glucose Meter Guidance Unveiled: A Discussion With the FDA," the director of FDA's Division of Chemistry and Toxicology Devices, Courtney Lias, PhD, will answer questions about the recently released draft guidance documents that establish new premarket submission requirements for blood glucose monitors.

PROFILES

Regulatory Profiles
Industry Profiles
Diagnostic Profiles
News From the FDA

Page Access:
Interactive Digital Edition



Next Month


Pharmacogenetics in Anticoagulant Testing: Boon or Bust?

Patients Granted Direct Access to Lab Reports